General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Investor relations contacts

If your question is not investment related, please contact the main switchboard:

Novartis International AG
Tel: +41 61 324 11 11

General IR questions, please contact our team.

For information relating to the registration of your shares, including name or address changes, please contact us online at share.registry@novartis.com or by mail or telephone:

Phone +41 61 324 72 04
Team

Peter Dreher
Head of Share Registry

Agnes Daester
Andrea Meehan-Schaefer
Michael Moran
Marco Preci

Mailing address:

Novartis International AG
Share Registry
WSJ-200.P.75
P.O.Box
CH-4002 Basel / Switzerland

+41 61 324 32 44

Stock chart